|

fezolinetant - reference formulation Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Shehzad Basaria, M.D.1

Indications

  • Hot Flushes and/or Sweats1
  • Hot Flushes1
  • Hot Flashes1
  • Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma1
  • Vasomotor Symptoms; Hot Flashes1

Boston, Massachusetts1 trial

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Brigham and Women's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.